Skip to content

To Compare Intranasal Dexmedetomidine And Intranasal Midazolam As Premedication In Paediatrics Patients Posted For Day Care Surgery

Comparison Of Intranasal Dexmedetomidine Versus Intranasal Midazolam As Premedication In Paediatrcis Patients Posted For Day Care Surgery. A Randomised Double Blinded Study. - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070471
Enrollment
102
Registered
2024-07-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K929- Disease of digestive system, unspecified

Interventions

Intervention1: Intranasal Dexmedetomidine: Intranasal Dexmedetomidine 2micrograms/kg drug diluted with 0.9% normal saline to total volume of 2ml for one group Control Intervention1: Intranasal Midazo

Sponsors

Department of Anaesthesiology And Critical care Jawaharlal Nehru Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 informed consent from parents or guardians 2 ASA grade I and II 3 patients undergoing paediatric day care surgery

Exclusion criteria

Exclusion criteria: 1 patients having an upper respiratory tract infection 2 Emergency cases 3 known allergies to study drugs 4 significant organ dysfunction 5 congenital disorders 6 more than eighty five percentile of body mass index for age percentiles

Design outcomes

Primary

MeasureTime frame
Parental separation anxiety scaleTimepoint: 30 mins

Secondary

MeasureTime frame
duration of hospital stayTimepoint: 24 hours;Hemodynamic parametersTimepoint: Zero min,5,10,15,20,30, min and 1 hour;Mask acceptance scaleTimepoint: 30 mins;Ramsay sedation scaleTimepoint: 30 mins;WATCHA scale of emergence deliriumTimepoint: 30 mins

Countries

India

Contacts

Public ContactFARAH NASREEN

Jawaharlal Nehru medical college, Aligarh Muslim University, Aligarh

kazmifarah@gmail.com9897067670

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026